Drug shortage
Dextrose Monohydrate 5% Injection · Fresenius Kabi USA, LLC
FDA drug shortage · Current · updated Apr 1, 2025
Key facts
| Generic name | Dextrose Monohydrate 5% Injection |
|---|---|
| Proprietary name | Dextrose 5% In Plastic Container |
| Company | Fresenius Kabi USA, LLC |
| Presentation | Dextrose 5% In Plastic Container, Injection, 50 mg/1 mL (NDC 63323-624-75) |
| Dosage form | Injection |
| Strength | 50 mg/1 mL |
| Status | Current |
| Reason for shortage | Demand increase for the drug |
| Therapeutic category | Endocrinology/Metabolism Gastroenterology Other Pediatric |
| Package NDCs | 63323-624-75 |
| First posted | Feb 14, 2022 |
| Last updated | Apr 1, 2025 |
At a glance
- 1–9 Package NDCs affected
- 10–99 FDA shortage records for this drug
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA drug shortages
The FDA Drug Shortages Database lists current and resolved shortages of drugs, with presentations, affected NDCs and reasons reported by manufacturers.
Source: U.S. Food and Drug Administration (FDA), Drug Shortages Database · Source date: